Effects of omega-3 carboxylic acids on lipoprotein particles and other cardiovascular risk markers in high-risk statin-treated patients with residual hypertriglyceridemia: a randomized, controlled, double-blind trial

Effect of Darapladib on Major Coronary Events After an Acute Coronary Syndrome

(2014) Michelle L. O’Donoghue et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Loss-of-Function Mutations in APOC3 and Risk of Ischemic Vascular Disease

(2014) Anders Berg Jørgensen et al.   NEW ENGLAND JOURNAL OF MEDICINE

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

A Highly Bioavailable Omega-3 Free Fatty Acid Formulation Improves the Cardiovascular Risk Profile in High-Risk, Statin-Treated Patients With Residual Hypertriglyceridemia (the ESPRIT Trial)

(2013) Kevin C. Maki et al.   CLINICAL THERAPEUTICS

Omega-3 polyunsaturated fatty acids in the treatment of hypertriglyceridaemia

(2013) Angela Pirillo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: The EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial

(2013) John J.P. Kastelein et al.   Journal of Clinical Lipidology

Relationship of Lipoprotein-Associated Phospholipase A2 Mass and Activity with Incident Vascular Events among Primary Prevention Patients Allocated to Placebo or to Statin Therapy: An Analysis from the JUPITER Trial

(2012) P. M. Ridker et al.   CLINICAL CHEMISTRY

Docosahexaenoic acid suppresses the expression of FoxO and its target genes

(2012) Yu-Jen Chen et al.   JOURNAL OF NUTRITIONAL BIOCHEMISTRY

Beneficial effects of omega-3 fatty acids in the proteome of high-density lipoprotein proteome

(2012) Elena Burillo et al.   Lipids in Health and Disease

Apolipoprotein CIII

(2011) Henry N. Ginsberg et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Low-Density Lipoproteins Containing Apolipoprotein C-III and the Risk of Coronary Heart Disease

(2011) Carlos O. Mendivil et al.   CIRCULATION

Effects of Eicosapentaenoic Acid Versus Docosahexaenoic Acid on Serum Lipids: A Systematic Review and Meta-Analysis

(2011) Melissa Y. Wei et al.   Current Atherosclerosis Reports

Apolipoprotein CIII Links Dyslipidemia with Atherosclerosis

(2011) Akio Kawakami et al.   Journal of Atherosclerosis and Thrombosis

Effects of prescription omega-3-acid ethyl esters, coadministered with atorvastatin, on circulating levels of lipoprotein particles, apolipoprotein CIII, and lipoprotein-associated phospholipase A2 mass in men and women with mixed dyslipidemia

(2011) Kevin C. Maki et al.   Journal of Clinical Lipidology

Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: A review

(2011) Terry A. Jacobson et al.   Journal of Clinical Lipidology

Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

(2011) Amit V. Khera et al.   NEW ENGLAND JOURNAL OF MEDICINE

Efficacy and tolerability of atorvastatin/fenofibrate fixed-dose combination tablet compared with atorvastatin and fenofibrate monotherapies in patients with dyslipidemia: A 12-week, multicenter, double-blind, randomized, parallel-group study

(2010) Michael H. Davidson et al.   CLINICAL THERAPEUTICS

Lipoprotein-associated phospholipase A2 and risk of coronary disease, stroke, and mortality: collaborative analysis of 32 prospective studies

(2010)   LANCET

Fish Oil Promotes Macrophage Reverse Cholesterol Transport in Mice

(2009) Tomoyuki Nishimoto et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

FoxO1 and hepatic lipid metabolism

(2009) Janet D Sparks et al.   CURRENT OPINION IN LIPIDOLOGY

Effects of prescription omega-3-acid ethyl esters on lipoprotein particle concentrations, apolipoproteins AI and CIII, and lipoprotein-associated phospholipase A2 mass in statin-treated subjects with hypertriglyceridemia

(2009) Michael H. Davidson et al.   Journal of Clinical Lipidology

Lipoprotein-Associated Phospholipase A2: An Independent Predictor of Coronary Artery Disease Events in Primary and Secondary Prevention

(2008) Jeffrey L. Anderson   AMERICAN JOURNAL OF CARDIOLOGY

Effects of Adding Prescription Omega-3 Acid Ethyl Esters to Simvastatin (20 mg/day) on Lipids and Lipoprotein Particles in Men and Women With Mixed Dyslipidemia

(2008) Kevin C. Maki et al.   AMERICAN JOURNAL OF CARDIOLOGY

Omega-3 fatty acids and coronary heart disease risk: Clinical and mechanistic perspectives

(2008) William S. Harris et al.   ATHEROSCLEROSIS

Genetics of arterial structure and function: towards new biomarkers for aortic stiffness?

(2008) Yasmin et al.   CLINICAL SCIENCE

ChREBP: A Glucose-activated Transcription Factor Involved in the Development of Metabolic Syndrome

(2008) Katsumi IIZUKA et al.   ENDOCRINE JOURNAL

A Null Mutation in Human APOC3 Confers a Favorable Plasma Lipid Profile and Apparent Cardioprotection

(2008) T. I. Pollin et al.   SCIENCE